Filing Details

Accession Number:
0001209191-20-002279
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-07 16:31:01
Reporting Period:
2020-01-03
Accepted Time:
2020-01-07 16:31:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296999 David Arkowitz C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-01-03 3,095 $0.00 88,481 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares to cover tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on March 1, 2019.
  2. The shares were sold at a range of prices between $19.76 and $19.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.